Concurrent development of high-stage cutaneous squamous cell carcinoma during complete response of metastatic cutaneous squamous cell carcinoma to programmed cell death protein 1 blockade with cemiplimab
Guardado en:
Autores principales: | Jacob D. Siegel, MD, Aarti Bhatia, MD, MPH, Christine J. Ko, MD, Sean R. Christensen, MD, PhD |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/00637970d09a41649c0ae007b9b72dcc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotherapy and Systemic Treatment of Cutaneous Squamous Cell Carcinoma
por: Nader Aboul-Fettouh, et al.
Publicado: (2021) -
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy
por: Sabino Strippoli, et al.
Publicado: (2021) -
Biology and Treatment Advances in Cutaneous Squamous Cell Carcinoma
por: Alesha A. Thai, et al.
Publicado: (2021) -
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
por: Anastasia V. Ignatova
Publicado: (2021) -
Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma
por: Gabriella Brancaccio, et al.
Publicado: (2021)